Clinical Trial Update: Topical Dexamethasone and Tacrolimus for the Treatment of Oral Chronic Graft-Versus-Host Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating topical dexamethasone and tacrolimus for oral chronic graft-versus-host disease has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Chronic Graft-versus-host Disease

Drugs mentioned

• Tacrolimus (Tacrolimus)
• Topical Dexamethasone (dexamethasone ophthalmic)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Oral Chronic Graft-versus-host Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-02-19